David Hovland
Conseiller Juridique Général chez ELEDON PHARMACEUTICALS, INC.
Postes actifs de David Hovland
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ELEDON PHARMACEUTICALS, INC. | Conseiller Juridique Général | 19/04/2021 | - |
Historique de carrière de David Hovland
Anciens postes connus de David Hovland
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| UROVANT SCIENCES LTD. | Conseiller Juridique Général | 01/04/2018 | 01/04/2021 |
| ALLERGAN PLC | Conseiller Juridique Général | 01/01/2015 | 01/01/2018 |
| Corporate Officer/Principal | 01/01/2010 | 01/01/2015 | |
| AMGEN INC. | Conseiller Juridique Général | 01/01/2006 | 01/01/2010 |
| ALLERGAN PLC | Corporate Officer/Principal | 01/01/1999 | 01/01/2002 |
Formation de David Hovland
| University of California, Los Angeles | Doctorate Degree |
| University of California, Berkeley | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Bermudes | 2 |
| Irlande | 2 |
Opérationnelle
| General Counsel | 4 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| ELEDON PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Urovant Sciences Ltd.
 Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of therapies for urologic conditions. Its pipeline includes Vibegron (RVT-901) and URO-902. The company was founded on January 27, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
- Bourse
- Insiders
- David Hovland
- Expérience
